Clinical Trials Directory

Trials / Completed

CompletedNCT06057493

RDP Reliability Study

Analytic Validation of the Optina Retinal Deep Phenotyping.TM (RDP) Platform

Status
Completed
Phase
Study type
Observational
Enrollment
43 (actual)
Sponsor
Optina Diagnostics Inc. · Industry
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

This is an observational study designed to assess the reliability and consistency of the Optina awAIrTM CAS Test for detecting phenotypic changes in the retina that are associated with beta-amyloid status (positive or negative). The purpose of this study is to ensure that the retinal image capture process is consistent and under control, regardless of the operator or the time of measurement. The study will include enough repeated measurements on different systems, by three operators, and at different times to demonstrate.

Detailed description

The purpose of this study is to assess the reliability of the Optina Retinal Deep Phenotyping.TM(RDP) platform. The RDP Platform is comprised of the Optina-4CTM retinal camera and its Optina-4C ConnectTM software, as well as the Optina awAIrTM-CAS Test (also called CAS Test) for detecting phenotypic changes in the retina that are associated with cerebral beta-amyloid status (positive or negative). This study will quantify points of variability in the data input for the CAS Test, including: * Left eye vs. right eye (retinal scan) * Eye algorithm selection (eye assessment obtained from different eye specialists either an Ophthalmologist or an Optometrist) * Hardware variability (Inter-instrument Variability retinal scans obtained from different Optina-4CTM cameras) * Inter-operator variability (retinal scans obtained from different Users of the Optina-4CTM camera) * Intra-operator variability (retinal scans obtained by the same user on the same Optina-4CTM camera

Conditions

Interventions

TypeNameDescription
OTHERRetinal Imaging with Optina4C CameraThe study consists of 2 visits and 8 Imaging sessions: The participant will go through four (8) imaging sessions in two visits with the Optina-4CTM cameras to get pictures of your retina. These imaging sessions will be done by three qualified operators who have been trained on the study device by Optina Diagnostics.

Timeline

Start date
2023-09-19
Primary completion
2024-02-06
Completion
2024-02-06
First posted
2023-09-28
Last updated
2024-02-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06057493. Inclusion in this directory is not an endorsement.